Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470788) titled 'FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation' on March 9.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Device Feasibility. Masking: None (Open Label).

Primary Sponsor: Vesalius Cardiovascular Inc.

Condition: Degenerative Mitral Regurgitation

Intervention: Device: Transcatheter Mitral Valve Repair

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 2026

Target Sample Size: 5

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/study/N...